Copyright
©The Author(s) 2022.
World J Hepatol. May 27, 2022; 14(5): 956-971
Published online May 27, 2022. doi: 10.4254/wjh.v14.i5.956
Published online May 27, 2022. doi: 10.4254/wjh.v14.i5.956
Figure 2 UBE2C, UBE2T, and UBE2S expression levels in hepatocellular carcinoma based on normal and tumor sample types and based on cancer stages (the Cancer Genome Atlas database).
A: Expression of UBE2C in hepatocellular carcinoma (HCC) based on sample types; B: Expression of UBE2T in HCC based on sample types; C: Expression of UBE2S in HCC based on sample types; D: Expression of UBE2C in HCC based on individual cancer stages; E: Expression of UBE2T in HCC based on individual cancer stages; F: Expression of UBE2S in HCC based on individual cancer stages (aP < 0.05; cP < 0.001).
- Citation: Zhang CY, Yang M. Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis. World J Hepatol 2022; 14(5): 956-971
- URL: https://www.wjgnet.com/1948-5182/full/v14/i5/956.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i5.956